BigRob finance professional

Directions Contact the business

BigRob finance professional Independent sales and finance expert specializing in vehicles, powersports, RVs, and boats. Personalized service and competitive rates.

Dedicated to helping you find and finance your next adventure. Contact me for a seamless buying experience! Sales and finance on new and used vehicles

Getting BIGGER while taking LESS testosterone and HGH than I was before! 💪🔥So what’s changed?I’ve cut back on my trainin...
10/17/2026

Getting BIGGER while taking LESS testosterone and HGH than I was before! 💪🔥

So what’s changed?

I’ve cut back on my training volume, doing fewer sets, taking longer rests between sets, and focusing more on recovery.

I also recently did a parasite cleanse, and I’m wondering if that’s helped my body function better and respond differently.

Is it the lower training volume and better recovery? The cleanse? Or a combination of both?

I can’t say for sure, but something is definitely working!

Just goes to show that sometimes doing MORE isn’t always the answer. Sometimes it’s about figuring out what YOUR body responds best to. 💯

My body used to be built on a strict diet and discipline. It was very difficult to avoid bad food and cravings. But Now!...
10/17/2026

My body used to be built on a strict diet and discipline. It was very difficult to avoid bad food and cravings. But Now!!!!! it's almost too easy on R£ta.

🚨 BIG NEWS FOR RETATRUTIDE! THIS COULD CHANGE MORE THAN PEOPLE REALIZE! 🧬Here’s something interesting happening behind t...
10/15/2026

🚨 BIG NEWS FOR RETATRUTIDE! THIS COULD CHANGE MORE THAN PEOPLE REALIZE! 🧬

Here’s something interesting happening behind the scenes in the peptide world that isn’t getting nearly enough attention.

The FDA has ruled that Retatrutide is classified as a DRUG, not a BIOLOGIC.

Now you might be thinking, what’s the big deal? Isn’t it already a drug?

Well, here’s where things get interesting. 👇

Retatrutide contains 39 amino acids, just one below the 40-amino-acid threshold used in the FDA’s definition of certain biological products.

That single amino acid makes a major difference in how the FDA regulates it.

And this isn’t just about scientific terminology. It could have real implications for:

💰 PRICING: How competition and regulatory protections could influence future costs.

🧪 COMPOUNDING: What pharmacies may legally be permitted to prepare and under what circumstances.

⚖️ PATENTS & EXCLUSIVITY: How different legal protections could affect future competition. Drug classification doesn’t automatically shorten patent protection.

Here’s another interesting part.

Eli Lilly is challenging the FDA’s position, showing just how significant this classification dispute could be.

We’re talking about a triple-receptor agonist targeting GLP-1, GIP and glucagon pathways, with some of the most talked-about weight-loss results in clinical research.

And now the legal and regulatory side is becoming almost as interesting as the science itself.

Does this mean Retatrutide is suddenly approved, cheaper or available for legal compounding? NO. Those are separate questions, and this decision doesn’t automatically change any of them.

But could this classification influence what happens when Retatrutide eventually reaches the market? Absolutely.

🔥 My question is: Could this ultimately mean more competition and better access, or will the legal battles keep things expensive?

Drop your thoughts below. 👇

Educational content only. Retatrutide remains investigational and is not FDA-approved.

Biotechnology WeightLossResearch PharmaceuticalIndustry

10/15/2026

🔥 ARA-290 & SS-31, TWO PEPTIDES GETTING SERIOUS ATTENTION IN THE LONGEVITY WORLD! 🧬⚡

I’ve covered both of these before, but the more you dig into the research, the more interesting they become.

🧬 ARA-290 (Cibinetide) — Being investigated for its potential role in:
✅ Nerve protection and repair
✅ Small fiber neuropathy
✅ Inflammation regulation
✅ Nerve-related pain
✅ Tissue recovery

⚡ SS-31 (Elamipretide) — Getting attention for its effects on:
✅ Mitochondrial function
✅ Cellular energy production
✅ Oxidative stress
✅ Muscle function and fatigue
✅ Cellular protection and healthy aging

💪 And here’s what makes the conversation even more interesting…

People in biohacking and fitness communities are sharing personal experiences involving better energy, improved stamina, reduced nerve discomfort, and faster recovery.

These are anecdotal reports, not proven clinical outcomes, but they’re helping drive interest in the research.

🔬 The science is evolving, and we’re only beginning to understand the potential applications of these compounds.

SS-31 already has FDA approval for a rare mitochondrial condition, while ARA-290 remains investigational. Neither is approved for general fitness or anti-aging.

🚨 Don’t just follow the hype. FOLLOW THE RESEARCH.

👇 Have you researched either of these peptides? What caught your attention the most?

Biohacking CellularHealth RecoveryScience HealthOptimization AntiAgingResearch

10/14/2026

🚨 THE NEXT BIG THING IN FAT-LOSS RESEARCH? 🔬🔥

Everybody’s been talking about Retatrutide, but there’s another peptide making serious waves in metabolic research, ELORALINTIDE!

What makes this one interesting is that it works through a completely different pathway. Instead of targeting GLP-1, GIP and glucagon receptors like Reta, it targets the amylin receptor, which plays a major role in appetite regulation and helping you feel fuller for longer.

📊 THE PHASE 2 RESULTS?

Researchers reported up to 20.1% average bodyweight reduction over 48 weeks!

And here’s what really catches my attention: could this different pathway eventually offer advantages for appetite control, tolerability, or combination therapies?

It’s still investigational, and there’s no direct evidence it’s superior to Reta, but the science is moving FAST! 🧬

💬 What do you think? Could amylin-based therapies become the next major breakthrough in weight management?

Follow for more fitness, metabolic health and peptide research updates! 💪

Educational content only. Eloralintide is an investigational compound and is not approved for clinical use.

FitnessScience WeightLossResearch HealthOptimization

10/06/2026

🚨 ARA-290 might be one of the most interesting research peptides I’ve looked into lately.

Also known as cibinetide, it’s being researched for its effects on the body’s inflammation, tissue-protection and repair pathways with human clinical research involving neuropathy and sarcoidosis. 🧬

The clinical research caught my attention… but some of the self-reports are what really sent me down the rabbit hole. 👀

Nerve health ⚡
Inflammatory signaling 🔥
Tissue protection 🧬
Recovery & repair 🔧

Still experimental. Still being researched. Definitely not something I’m calling a proven treatment.

But ARA-290 is one I’ll be watching closely. 👀

Educational content only. Not medical advice.

Still got it 💪
10/06/2026

Still got it 💪

I don’t really know how to deal with pain other than the gym. It’s always been the one place I can turn everything off a...
10/05/2026

I don’t really know how to deal with pain other than the gym. It’s always been the one place I can turn everything off and just work.

If anyone knows something more therapeutic, fill me in. I’m still figuring this s**t out. 🖤

Back in my prime, but all that mattered was getting huge and strong. Now i value god, family, health and wealth!
10/05/2026

Back in my prime, but all that mattered was getting huge and strong. Now i value god, family, health and wealth!

100% need a vacation!
10/05/2026

100% need a vacation!

Address

Winnipeg Byps
Winnipeg, MB
R3X

Opening Hours

Monday 9am - 9pm
Tuesday 9am - 9pm
Wednesday 9am - 9pm
Thursday 9am - 9pm
Friday 9am - 9pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when BigRob finance professional posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BigRob finance professional:

Shortcuts

Share

Category